BBS2
protein-codingBardet-Biedl syndrome 2, the group of BBSome
Gene summary
This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with seven other BBS proteins.[provided by RefSeq, Oct 2014]
- BBS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~117.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014432
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:1040048
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014432
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0014432
Submitter: Myriad Women's Health
Inheritance Pattern: AR
Disease ID:MONDO:0014432
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0014692
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014432
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014432
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:1040048
Submitter: ClinGen
*BBS2* was first reported in relation to autosomal recessive Bardet-Biedl Syndrome in 2001 (Nishimura et al., PMID: 11285252). Per criteria outlined by the ClinGen Lumping & Splitting Working Group, the mode of inheritance (autosomal recessive) and molecular mechanism (biallelic *BBS2* loss of function) have been found to be consistent among patients diagnosed with either Bardet-Biedl syndrome 2 (MIM#: 606151) or retinitis pigmentosa 74 (MIM#: 616562), while the phenotypic variability between the two groups of cases appears to represent a spectrum of disease rather than separate disease entities. Therefore, cases caused by inherited biallelic *BBS2* variants have been lumped into a single disease entity, referred to as *BBS2*-related ciliopathy. Nine unique variants (two missense, three nonsense, one frameshift, and three splicing) that have been reported in thirteen probands in five publications (PMIDs: 11567139, 11285252, 24608809, 21052717, 33777945) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be biallelic loss-of-function. This gene-disease association is also supported by data from ProteinAtlas that *BBS2* is non-specifically expressed in the retina as well as many other tissues, consistent with the clinical heterogeneity of Bardet-Biedl syndrome (PMID: 28940711). Biochemical evidence indicates that the protein encoded by the *BBS2* gene is a component of the BBSome, a protein complex that functions in ciliogenesis and intraflagellar transport (PMID: 22072986). Tandem affinity purification followed by mass spectrometry has shown that *BBS2* forms a stable complex along with other proteins that are encoded by genes associated with Bardet-Biedl syndrome (*BBS1*, *BBS4*, *BBS5*, *BBS7*, *BBS8*, and *BBS9*, PMID: 17574030). *BBS2* homozygous knockout zebrafish without a functional copy of *BBS2* exhibit retinal degeneration and vision loss (PMID: 33324636). A *Bbs2* null mouse model recapitulated even more of the features of human patients, including obesity, retinal degeneration, renal cysts, and male infertility (PMID: 15539463). In summary, *BBS2* is definitively associated with autosomal recessive BBS2-related ciliopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Retina Gene Curation Expert Panel on March 7th, 2024 (SOP Version 10).
Inheritance Pattern: AD
Disease ID:MONDO:0019200
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014692
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0015229
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Gastrointestinal; Genitourinary; Endocrine; Musculoskeletal; Neurologic; Ophthalmologic; Renal
Intervention: Endocrine
Rationale: Medical management of obesity with melanocortin-4 receptor (MC4R) agonist (setmelanotide) may be beneficial
Comments: Variants may modify the severity of BBS and related disorders due to variants in other BBS-associated genes
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BBS2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_031885.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 15 | 324 | 1 | 344 | |
| missense | 4 | 31 | 415 | 15 | 1 | 466 |
| nonsense | 21 | 39 | 1 | 61 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 59 | 85 | 1 | 145 | ||
| splice donor/acceptor (+/-2bp) | 14 | 50 | 1 | 65 | ||
| Total | 99 | 210 | 433 | 339 | 2 | 1083 |
Highest pathogenic variant AF is 0.00025774792
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_114091.4 | 17 | MANE Select | |
| Ensembl | ENSP00000245157.5 | 17 | MANE Select | |
| RefSeq | NP_001364385.1 | 17 | Standard | |
| Ensembl | ENSP00000454986.2 | 4 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| bbs2 | Danio rerio | Structure: pronephric proximal convoluted tubule Quality: morphology abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- BBSome-mediated cargo-targeting to cilium
- Cargo trafficking to the periciliary membrane
- Cilium Assembly
- Organelle biogenesis and maintenance
Biological Process
- sperm axoneme assembly
- visual perception
- protein localization
- negative regulation of gene expression
- artery smooth muscle contraction
Molecular Function
- RNA polymerase II repressing transcription factor binding
- protein binding
Cellular Component
- cytosol
- microvillus
- membrane
- motile cilium
- stereocilium
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000245157
- Coding exons
- 17
- Length
- 53448
- Individuals with no LoFs
- 125556
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 192
- Defined
- 125748
- p
- 0.000764
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.870 | 351 | 400 | 0.878 | 0.0000226 | 4752 |
| Missense (PolyPhen) | 125 | 148.28 | 0.843 | 1781 | ||
| Synonymous | 0.243 | 143 | 147 | 0.975 | 0.00000775 | 1426 |
| Loss of Function | 1.22 | 31 | 39.3 | 0.790 | 0.00000262 | 410 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00020 | 0.00020 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.0022 | 0.0022 | notable |
| Finnish | 0.00088 | 0.00088 | rare |
| European (Non-Finnish) | 0.00091 | 0.00091 | rare |
| South Asian | 0.00042 | 0.00042 | rare |
| Other | 0.00082 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the ciliary membrane and binds to RAB3IP/Rabin8, the guanosyl exchange factor (GEF) for Rab8 and then the Rab8-GTP localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane. The BBSome complex, together with the LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway regulation. Required for proper BBSome complex assembly and its ciliary localization. {ECO:0000269|PubMed:17574030, ECO:0000269|PubMed:22072986}.;
- Disease
- DISEASE: Retinitis pigmentosa 74 (RP74) [MIM:616562]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:25541840}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0955
Intolerance Scores
- LoFtool
- 0.233
- RVIS EVS
- -0.84
- RVIS percentile EVS
- 11.36
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.805
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |